Literature DB >> 17978533

Carotid atherosclerosis in normal-weight metabolic syndrome.

Ryuichi Kawamoto1, Nobuyuki Ohtsuka, Daisuke Ninomiya, Syunpei Nakamura.   

Abstract

OBJECTIVE: To examine whether or not individuals with a normal body mass index (BMI) (18.5 kg/m(2)-24.9 kg/m(2)), but who also fulfill the criteria for the metabolic syndrome (MetS) class, can be associated with carotid atherosclerosis.
METHODS: The subjects were consecutive in-patients with a normal BMI (18.5 kg/m(2)-24.9 kg/m(2)) in the Medical Department of Seiyo Municipal Nomura Hospital enrolled between September 1996 and February 2006. The subjects were 452 men aged 69+/-15 (mean+/-standard deviation) years and 542 women aged 74+/-13 years. Carotid atherosclerosis was assessed by carotid intima-media thickness (IMT) on B-mode ultrasonography.
RESULTS: Compared with men with BMI 18.5 kg/m(2) to 20.9 kg/m(2), the odds ratios of the MetS were 2.83 (95% confidence interval [CI], 1.69-4.76) for men with BMI 21 kg/m(2) to 22.9 kg/m(2) and 6.13 (95% CI, 3.57-10.5) for men with BMI 23.0 kg/m(2) to 24.9 kg/m(2) after controlling for age, smoking status, high low-density lipoprotein cholesterol, and uric acid. Using the same regression model and BMI categories in women, the odds ratios were 2.52 (95% CI, 1.42-2.83) and 4.38 (95% CI, 2.42-7.92), respectively. Multivariate-adjusted carotid IMT was significantly greater in men with than without MetS, especially in patients with BMI 23.0 kg/m(2) to 24.9 kg/m(2). Although in women, there were no inter-group differences in categories of normal BMI and MetS.
CONCLUSION: Individuals in the upper normal BMI range have a relatively high prevalence and are at increased risk of having metabolic syndrome. Therefore, screening of individuals with normal or slightly elevated BMI is important in preventing atherosclerosis.

Entities:  

Mesh:

Year:  2007        PMID: 17978533     DOI: 10.2169/internalmedicine.46.0261

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

1.  Baseline and changes in serum uric acid independently predict 11-year incidence of metabolic syndrome among community-dwelling women.

Authors:  R Kawamoto; D Ninomiya; Y Kasai; K Senzaki; T Kusunoki; N Ohtsuka; T Kumagi
Journal:  J Endocrinol Invest       Date:  2018-02-19       Impact factor: 4.256

2.  Subclinical atherosclerosis and metabolic risk: role of body mass index and waist circumference.

Authors:  Sarah M Camhi; Peter T Katzmarzyk; Stephanie T Broyles; Sathanur R Srinivasan; Wei Chen; Claude Bouchard; Gerald S Berenson
Journal:  Metab Syndr Relat Disord       Date:  2010-12-06       Impact factor: 1.894

3.  Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults.

Authors:  Ryuichi Kawamoto; Yasuharu Tabara; Katsuhiko Kohara; Tetsuro Miki; Tomo Kusunoki; Shuzo Takayama; Masanori Abe; Tateaki Katoh; Nobuyuki Ohtsuka
Journal:  Lipids Health Dis       Date:  2011-05-17       Impact factor: 3.876

4.  High-sensitivity C-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons.

Authors:  Ryuichi Kawamoto; Yasuharu Tabara; Katsuhiko Kohara; Tetsuro Miki; Tomo Kusunoki; Shuzo Takayama; Masanori Abe; Tateaki Katoh; Nobuyuki Ohtsuka
Journal:  Cardiovasc Diabetol       Date:  2010-12-09       Impact factor: 9.951

5.  Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults.

Authors:  Ryuichi Kawamoto; Yasuharu Tabara; Katsuhiko Kohara; Tetsuro Miki; Tomo Kusunoki; Shuzo Takayama; Masanori Abe; Tateaki Katoh; Nobuyuki Ohtsuka
Journal:  Lipids Health Dis       Date:  2010-12-07       Impact factor: 3.876

6.  Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women.

Authors:  Ryuichi Kawamoto; Yasuharu Tabara; Katsuhiko Kohara; Tetsuro Miki; Tomo Kusunoki; Shuzo Takayama; Masanori Abe; Tateaki Katoh; Nobuyuki Ohtsuka
Journal:  Endocrine       Date:  2013-03-09       Impact factor: 3.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.